Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT.
Although prolonged periods of neutropenia are common following induction and intensification of chemotherapy, this study showed that pediatric patients with AML can be safely managed in the outpatient setting after resolution of neutropenia.
Although previous population-based studies have shown worse clinical outcomes for minority patients with DLBCL compared with white patients, this study reported no differences in PFS and OS were seen between the 2 groups.
Researchers assessed a method of extracting marrow cells and transforming them to promote fetal hemoglobin generation in patients with sickle cell disease.
Eligibility criteria for this study included intermediate- or high-risk cytogenetics, and CR or CR with incomplete count recovery following induction chemotherapy.
Adding aspirin to direct-acting oral anticoagulant therapy without a clear indication may increase bleeding risk without decreasing thrombotic risk.
Patients with hemophilia A reported a median improvement of 2.25 points in hemophilia joint health score during the course of the study.
Risk for postpartum hemorrhage after cesarean delivery was nearly 2-fold greater in patients with mild factor XI deficiency compared with the control cohort.
While PRO-CTCAEs capture patient reports of particular symptomatic AEs, the “toxicity over time” approach provides a longitudinal assessment of these AEs.
In this study, claims data from CMS were used to estimate health care utilization of patients with DLCBL before and after CAR-T therapy.